Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient
Joshua A. Hill, Chaitra S. Ujjani, Alexander L. Greninger, Mazyar Shadman, Ajay K. Gopal
Topics & Concepts
MedicineImmunogenicityVaccinationSeroconversionCancerPopulationVirologyLymphomaImmunologyAntibodyInternal medicineEnvironmental healthSARS-CoV-2 and COVID-19 ResearchCancer Immunotherapy and BiomarkersCAR-T cell therapy research